Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $77.11 billion. The enterprise value is $99.67 billion.
Important Dates
The last earnings date was Wednesday, January 28, 2026, before market open.
| Earnings Date | Jan 28, 2026 |
| Ex-Dividend Date | Mar 10, 2026 |
Share Statistics
Elevance Health has 222.24 million shares outstanding. The number of shares has decreased by -3.56% in one year.
| Current Share Class | 222.24M |
| Shares Outstanding | 222.24M |
| Shares Change (YoY) | -3.56% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 91.71% |
| Float | 221.75M |
Valuation Ratios
The trailing PE ratio is 13.76 and the forward PE ratio is 13.29. Elevance Health's PEG ratio is 2.67.
| PE Ratio | 13.76 |
| Forward PE | 13.29 |
| PS Ratio | 0.39 |
| Forward PS | 0.37 |
| PB Ratio | 1.75 |
| P/TBV Ratio | 17.78 |
| P/FCF Ratio | 24.30 |
| P/OCF Ratio | 17.97 |
| PEG Ratio | 2.67 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.09, with an EV/FCF ratio of 31.40.
| EV / Earnings | 17.60 |
| EV / Sales | 0.50 |
| EV / EBITDA | 10.09 |
| EV / EBIT | 11.96 |
| EV / FCF | 31.40 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.73.
| Current Ratio | 1.54 |
| Quick Ratio | 1.41 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 3.24 |
| Debt / FCF | 10.10 |
| Interest Coverage | 5.94 |
Financial Efficiency
Return on equity (ROE) is 13.25% and return on invested capital (ROIC) is 9.24%.
| Return on Equity (ROE) | 13.25% |
| Return on Assets (ROA) | 4.37% |
| Return on Invested Capital (ROIC) | 9.24% |
| Return on Capital Employed (ROCE) | 10.36% |
| Weighted Average Cost of Capital (WACC) | 6.10% |
| Revenue Per Employee | $1.91M |
| Profits Per Employee | $54,338 |
| Employee Count | 104,200 |
| Asset Turnover | 1.67 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $1.05 billion in taxes.
| Income Tax | 1.05B |
| Effective Tax Rate | 15.63% |
Stock Price Statistics
The stock price has decreased by -14.41% in the last 52 weeks. The beta is 0.52, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -14.41% |
| 50-Day Moving Average | 348.93 |
| 200-Day Moving Average | 347.54 |
| Relative Strength Index (RSI) | 45.11 |
| Average Volume (20 Days) | 1,688,058 |
Short Selling Information
The latest short interest is 3.69 million, so 1.66% of the outstanding shares have been sold short.
| Short Interest | 3.69M |
| Short Previous Month | 4.76M |
| Short % of Shares Out | 1.66% |
| Short % of Float | 1.66% |
| Short Ratio (days to cover) | 2.81 |
Income Statement
In the last 12 months, Elevance Health had revenue of $199.13 billion and earned $5.66 billion in profits. Earnings per share was $25.21.
| Revenue | 199.13B |
| Gross Profit | 50.90B |
| Operating Income | 8.33B |
| Pretax Income | 6.71B |
| Net Income | 5.66B |
| EBITDA | 9.88B |
| EBIT | 8.33B |
| Earnings Per Share (EPS) | $25.21 |
Full Income StatementBalance Sheet
The company has $36.12 billion in cash and $32.05 billion in debt, with a net cash position of -$22.56 billion or -$101.49 per share.
| Cash & Cash Equivalents | 36.12B |
| Total Debt | 32.05B |
| Net Cash | -22.56B |
| Net Cash Per Share | -$101.49 |
| Equity (Book Value) | 44.03B |
| Book Value Per Share | 197.84 |
| Working Capital | 21.97B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.29 billion and capital expenditures -$1.12 billion, giving a free cash flow of $3.17 billion.
| Operating Cash Flow | 4.29B |
| Capital Expenditures | -1.12B |
| Free Cash Flow | 3.17B |
| FCF Per Share | $14.28 |
Full Cash Flow StatementMargins
Gross margin is 25.56%, with operating and profit margins of 4.19% and 2.84%.
| Gross Margin | 25.56% |
| Operating Margin | 4.19% |
| Pretax Margin | 3.37% |
| Profit Margin | 2.84% |
| EBITDA Margin | 4.96% |
| EBIT Margin | 4.19% |
| FCF Margin | 1.59% |
Dividends & Yields
This stock pays an annual dividend of $6.88, which amounts to a dividend yield of 1.98%.
| Dividend Per Share | $6.88 |
| Dividend Yield | 1.98% |
| Dividend Growth (YoY) | 3.79% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 27.17% |
| Buyback Yield | 3.56% |
| Shareholder Yield | 5.55% |
| Earnings Yield | 7.34% |
| FCF Yield | 4.12% |
Dividend DetailsAnalyst Forecast
The average price target for Elevance Health is $391.94, which is 12.96% higher than the current price. The consensus rating is "Buy".
| Price Target | $391.94 |
| Price Target Difference | 12.96% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 17.90% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
